Sweden to merge drug and device authorities?:
This article was originally published in Clinica
The Swedish authorities are considering whether medical device and pharmaceutical regulation should be dealt with by a single agency. The National Board of Health and Welfare, which includes a medical devices unit, has been holding preliminary discussions with the Medicines Products Agency to decide whether a merger would be appropriate. The Medicines Products Agency is responsible for pharmaceutical and cosmetics regulations. Several other European countries have been considering the advantages of bringing the two regulatory sectors together - France has recently set up its Agency for Healthcare Product Safety, which covers both drugs and devices, while in the UK the Medicines Control Agency and the Medical Devices Agency have decided to reject merger proposals for the time being.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.